Search Results - Pilon D
- Showing 1 - 6 results of 6
-
1
Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic by Pilon D, Joshi K, Tandon N, Lafeuille M, Kamstra RL, Emond B, Lefebvre P
Published in Patient Preference and Adherence (2017-03-01)Get full text
Article -
2
Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey by Zhdanava M, Starr HL, Totev TI, Lefebvre P, Shah A, Sheng K, Pilon D
Published in Neuropsychiatric Disease and Treatment (2022-09-01)Get full text
Article -
3
Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provid... by Zhdanava M, Starr HL, Lefebvre P, Totev TI, Shah A, Sheng K, Pilon D
Published in Neuropsychiatric Disease and Treatment (2022-07-01)Get full text
Article -
4
Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis by Zhdanava M, Kachroo S, Shah A, Ding Z, Lefebvre P, Zhao R, Kerner C, Pilon D
Published in Patient Preference and Adherence (2024-04-01)Get full text
Article -
5
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established... by Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J
Published in International Journal of COPD (2017-06-01)Get full text
Article -
6
Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race by Bilen MA, Khilfeh I, Rossi C, Muser E, Morrison L, Hilts A, Diaz L, Lefebvre P, Pilon D, George DJ
Published in ClinicoEconomics and Outcomes Research (2024-09-01)Get full text
Article
